Canada Pension Plan Investment Board Has $39.38 Million Stock Position in The Clorox Company $CLX

Key Points

• The Canada Pension Plan Investment Board cut its stake in The Clorox Company by 30.8%, selling 119,250 shares, and now owns 267,424 shares valued at approximately $39.4 million.
• Analysts have been adjusting their price targets for Clorox, with Morgan Stanley lowering their target from $150 to $137, while Wells Fargo raised theirs from $135 to $138.
• Clorox recently announced a quarterly dividend increase to $1.24, reflecting a positive change from the previous dividend, and presenting a dividend yield of 4.2%.

Canada Pension Plan Investment Board lowered its position in shares of The Clorox Company (NYSE:CLX - Free Report) by 30.8% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 267,424 shares of the company's stock after selling 119,250 shares during the period. Canada Pension Plan Investment Board owned approximately 0.22% of Clorox worth $39,378,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently bought and sold shares of CLX. Wood Tarver Financial Group LLC acquired a new stake in shares of Clorox during the fourth quarter worth approximately $31,000. GW&K Investment Management LLC lifted its position in Clorox by 239.1% in the 1st quarter. GW&K Investment Management LLC now owns 295 shares of the company's stock valued at $43,000 after purchasing an additional 208 shares during the last quarter. Roble Belko & Company Inc increased its position in Clorox by 140.7% in the 1st quarter. Roble Belko & Company Inc now owns 361 shares of the company's stock valued at $53,000 after acquiring an additional 211 shares during the period. Menard Financial Group LLC bought a new stake in shares of Clorox during the 4th quarter worth about $63,000. Finally, IMA Advisory Services Inc. bought a new stake in shares of Clorox in the 1st quarter worth $58,000. Hedge funds and other institutional investors own 78.53% of the company's stock.

Clorox Stock Performance

Shares of NYSE CLX traded up $1.52 during trading hours on Thursday, hitting $124.43. 1,629,328 shares of the company's stock were exchanged, compared to its average volume of 1,656,492. The company's 50-day moving average price is $123.87 and its 200-day moving average price is $133.78. The Clorox Company has a 1-year low of $116.53 and a 1-year high of $171.37. The stock has a market capitalization of $15.22 billion, a price-to-earnings ratio of 19.07, a PEG ratio of 0.94 and a beta of 0.52. The company has a debt-to-equity ratio of 5.15, a current ratio of 0.84 and a quick ratio of 0.57.

Clorox (NYSE:CLX - Get Free Report) last posted its quarterly earnings results on Thursday, July 31st. The company reported $2.87 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.24 by $0.63. The company had revenue of $1.99 billion for the quarter, compared to analyst estimates of $1.94 billion. Clorox had a net margin of 11.40% and a return on equity of 377.86%. The business's quarterly revenue was up 4.5% on a year-over-year basis. During the same period last year, the business posted $1.82 EPS. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. On average, sell-side analysts expect that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, August 29th. Investors of record on Wednesday, August 13th were given a $1.24 dividend. This represents a $4.96 annualized dividend and a yield of 4.0%. This is a boost from Clorox's previous quarterly dividend of $1.22. The ex-dividend date of this dividend was Wednesday, August 13th. Clorox's dividend payout ratio (DPR) is currently 76.07%.

Analyst Ratings Changes

A number of brokerages recently weighed in on CLX. UBS Group reduced their target price on shares of Clorox from $150.00 to $134.00 and set a "neutral" rating for the company in a report on Thursday, July 17th. Jefferies Financial Group dropped their price target on shares of Clorox from $167.00 to $145.00 and set a "buy" rating on the stock in a research note on Thursday, June 26th. Barclays lowered their target price on Clorox from $129.00 to $119.00 and set an "underweight" rating on the stock in a research note on Tuesday, July 15th. Citigroup restated a "neutral" rating and issued a $135.00 price objective (down previously from $140.00) on shares of Clorox in a report on Tuesday, July 15th. Finally, Wells Fargo & Company lifted their target price on shares of Clorox from $135.00 to $138.00 and gave the company an "equal weight" rating in a research note on Friday, August 1st. One research analyst has rated the stock with a Buy rating, eight have given a Hold rating and three have issued a Sell rating to the company's stock. According to data from MarketBeat, Clorox has a consensus rating of "Reduce" and a consensus target price of $143.36.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.